Interactions of ruthenium(II) compounds with sulfasalazine and N,N′-heterocyclic ligands with proteins

作者: Ariane Carla Campos de Melo , Jaime Murilo Salvo Vidal Pereira Santana , Kelen Jorge Rodrigues da Costa Nunes , Mayra de Amorim Marques , Guilherme Augusto Piedade de Oliveira

DOI: 10.1016/J.ICA.2017.08.037

关键词:

摘要: Abstract Two complexes of Ru(II) possessing the general formula [Ru(ssz) 2 L](PF 6 ) were prepared, in which ssz is sulfasalazine and L either 2,2′-bipyridine ( 1 or 1,10-phenanthroline ). The characterized by elemental conductivity analyses, UV–Vis, vibrational, NMR electrospray ionization mass spectroscopies. geometry around ruthenium(II) distorted octahedral. metal ion bound to carboxylate a bidentate way two heterocyclic nitrogens bpy phen. Spectrofluorimetric measurements indicate that bind BSA with affinity constants ranging from 10 4 5  M −1 . Both compounds are significantly cytotoxic chronic myelogenous leukemia cell line concentration dependent manner. UV-light exposure for 5 min increases cytotoxicity three times ten times. In addition, upon UV light irradiation, able damage bovine serum albumin molecule, at concentrations do not affect dark conditions. It worth note also Abl-SH3 protein, responsible development leukemia. Interactions proteins seem be significant photocytotoxic activity these complexes.

参考文章(37)
A. Bergamo, C. Gaiddon, J.H.M. Schellens, J.H. Beijnen, G. Sava, Approaching tumour therapy beyond platinum drugs : status of the art and perspectives of ruthenium drug candidates. Journal of Inorganic Biochemistry. ,vol. 106, pp. 90- 99 ,(2012) , 10.1016/J.JINORGBIO.2011.09.030
Vishwas D Suryawanshi, Laxman S Walekar, Anil H Gore, Prashant V Anbhule, Govind B Kolekar, None, Spectroscopic analysis on the binding interaction of biologically active pyrimidine derivative with bovine serum albumin. Journal of Pharmaceutical Analysis. ,vol. 6, pp. 56- 63 ,(2016) , 10.1016/J.JPHA.2015.07.001
B Senthamarai Kannan, D Suresh Kumar, R Host Antony David, A Stalin, S Ignacimuthu, None, Acid–base effects, light emission, DNA-binding and photocleavage studies of oligo-homonuclear ruthenium(II) complexes and their computational study Inorganica Chimica Acta. ,vol. 432, pp. 158- 168 ,(2015) , 10.1016/J.ICA.2015.03.042
Alketa Tarushi, Xanthippi Totta, Athanasios Papadopoulos, Jakob Kljun, Iztok Turel, Dimitris P. Kessissoglou, George Psomas, Antioxidant activity and interaction with DNA and albumins of zinc–tolfenamato complexes. Crystal structure of [Zn(tolfenamato)2(2,2′-dipyridylketoneoxime)2] European Journal of Medicinal Chemistry. ,vol. 74, pp. 187- 198 ,(2014) , 10.1016/J.EJMECH.2013.12.019
B. P. Sullivan, D. J. Salmon, T. J. Meyer, Mixed phosphine 2,2'-bipyridine complexes of ruthenium Inorganic Chemistry. ,vol. 10, pp. 3334- 3341 ,(1978) , 10.1021/IC50190A006
Paranthaman Vijayan, Periasamy Viswanathamurthi, Vaidhyanathan Silambarasan, Devadasan Velmurugan, Krishnaswamy Velmurugan, Raju Nandhakumar, Ray Jay Butcher, Tamilselvan Silambarasan, Ramamurthy Dhandapani, Dissymmetric thiosemicarbazone ligands containing substituted aldehyde arm and their ruthenium(II) carbonyl complexes with PPh3/AsPh3 as ancillary ligands: Synthesis, structural characterization, DNA/BSA interaction and in vitro anticancer activity Journal of Organometallic Chemistry. ,vol. 768, pp. 163- 177 ,(2014) , 10.1016/J.JORGANCHEM.2014.06.026
Angela Casini, Claudia Temperini, Chiara Gabbiani, Claudiu T. Supuran, Luigi Messori, The x-ray structure of the adduct between NAMI-A and carbonic anhydrase provides insights into the reactivity of this metallodrug with proteins ChemMedChem. ,vol. 5, pp. 1989- 1994 ,(2010) , 10.1002/CMDC.201000331
Yao Zhang, Andy Ho, Jiping Yue, Linlin Kong, Zuping Zhou, Xiaoyang Wu, Feng Yang, Hong Liang, Structural basis and anticancer properties of ruthenium-based drug complexed with human serum albumin. European Journal of Medicinal Chemistry. ,vol. 86, pp. 449- 455 ,(2014) , 10.1016/J.EJMECH.2014.08.071